drugset / Trial / NCT04907825

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

NCT04907825

NaSingle-groupOpen-labelPrevention

Summary

This is a prospective, single-arm, feasibility pilot study of 20 participants (aged 60 years or older, with additional stroke risk factors and 'actionable' undertreated AF) recruited from a total of 4 retail and outpatient community pharmacies. Eligible participants will be enrolled in a 3-month active intervention of pharmacist-led OAC management. Participants will be passively followed for an additional 9 months to determine safety endpoints.

Timeline

Start
2023-03-13
Primary completion
2025-08-31
Completion
2026-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule Oral